Are We Underpricing or Leaving Money on the Table in Healthcare Providers?
Direct answer: Most healthcare providers leave money on the table not through obviously low list prices, but through weak realized pricing — undisciplined payer contracts, unbilled or under-coded services, and a service mix skewed toward low-margin volume. A Pricing Power Analysis tells you whether you actually have the leverage to hold or raise prices, or whether you're a price-taker who must fix realization and mix instead. The two problems require opposite responses, and confusing them is what quietly costs providers margin.
Disclosure: I work on content for Percision, an AI strategic-intelligence platform. I'll explain where it fits and where a spreadsheet or a human consultant is the better call.
What Pricing Power Analysis actually measures
Pricing Power Analysis asks one question: if you raised prices, what would happen to volume, and who decides? For most industries that's a customer-elasticity question. In healthcare provision, the answer is more layered because the person receiving care rarely pays the price, and the payer who does pay is often locked into contracts.
So the framework splits into four honest sub-questions:
- Who is the price-setter? Commercial payers, Medicare/Medicaid (largely fixed), self-pay patients, or bundled/value-based arrangements. Your leverage differs radically across these buckets.
- What is your negotiating position with each payer? Determined by network necessity — are you a must-have in your geography, a specialty others can't easily replicate, or one of many interchangeable options?
- What is your realization gap? The distance between what you're contractually owed and what you actually collect after denials, under-coding, write-offs, and self-pay bad debt.
- What is your mix telling you? High volume in low-margin, price-fixed services (routine Medicaid visits) can mask strong pricing power in specialty lines you're under-investing in.
"Good" looks like this: you can name your top payer contracts by margin, you know your realization rate per service line, and you can point to at least one clinical service where you are genuinely differentiated — meaning you're a price-maker, not a price-taker. If you can't answer these without a two-week data pull, that gap is the finding.
A concrete walkthrough for a provider organization
Take a multi-site outpatient specialty group. Run the framework in sequence.
Step 1 — Segment revenue by payer and service line. Don't average. A group can look margin-healthy overall while a Medicaid-heavy site drains the specialty imaging line that's actually carrying the business.
Step 2 — Score price-setter leverage per segment. Ask: Could this payer drop us and adequately serve their members in this market? If no, you have contract leverage you may not be using. If yes, you're a taker — stop hoping for rate increases and go fix realization.
Step 3 — Quantify the realization gap. Pull denial rates, days in A/R, and coding accuracy. This is where the phrase "leaving money on the table" is usually most literal. Under-coding and preventable denials are recovered margin with no volume risk — the highest-quality dollars you can find.
Step 4 — Stress-test differentiation. For each specialty line, ask what a patient or referring physician would do if you weren't available. Genuine scarcity (subspecialty expertise, wait-time advantage, outcomes data) is pricing power. "We're friendly" is not.
Step 5 — Model the moves. For price-taker segments: realization and cost-to-serve. For price-maker segments: renegotiate contracts, expand capacity, or reweight the schedule toward those services.
The output should be a one-page map: here's where we can push price, here's where we can't, and here's the collectable revenue we're already owed.
Where Percision fits — and where it doesn't
Percision runs your business context through a structured reasoning process (its Pricing Power Analysis framework is one of 27+) and produces a board-ready read in roughly 7–15 minutes: segment-level leverage scoring, scenario modeling for rate and mix changes, and an Excel-exportable model with an audit trail your CFO can interrogate. It's positioned as a co-pilot, not an autopilot — it structures the analysis and pressure-tests your logic; your leadership team keeps every decision.
Independent research supports the general pattern that AI tools raise knowledge-worker throughput — a 2023 study by Harvard Business School, BCG, and others found consultants using GPT-4 completed tasks faster and at higher quality on suitable problems. Treat that as directional evidence for speed, not a promise about your specific pricing outcome.
Use Percision when you want a fast, framework-disciplined first pass across many payers and service lines, need to align a leadership team quickly, or want scenario decks before a board or contracting cycle.
Skip it when:
- Your problem is a single payer renegotiation — a sharp CFO with a spreadsheet and your contract terms will do fine.
- Your realization gap is an operational fix (coding, denials workflow). That's a revenue-cycle consultant or your RCM vendor, not a strategy platform.
- You lack clean payer-mix and realization data. No tool, AI or otherwise, fixes garbage inputs. Instrument first.
Percision also doesn't handle payer-specific regulatory compliance or clinical coding rules — those need domain specialists. It tells you where the money is; execution stays human.
What this looks like when the analysis is actually run
A provider group rarely sets its own prices. The money left on the table is usually in what it fails to collect and what it fails to claim.
The subject is Cedar Ridge Health Partners, a sample company profile we use for testing rather than a customer: a physician-owned multi-specialty group, $196M net patient revenue, 128 physicians, 14 clinics.
Excerpt from a real Percision run · Customer Value Architecture (T14) · sample company profile
The uncollected money. Denial-leakage recovery of $6–9M annually funds 60% of the platform build; a parallel run puts revenue-cycle recovery at $4.6–6.9M.
The unclaimed money. A 15–25% platform margin on the $91.2M shared-savings pool, with an expected NPV upside of $22.8M. The platform replaces a 90-day manual chart abstraction process with a 30-day lag, enabling the group to negotiate shared-savings upside and downside caps with actuarial precision.
The money it could charge others for. Turn a $6.8M downside-risk liability into a $22–35M licensing platform within 36 months. Year 2: $4.2M licensing ARR at 40 physicians × $120K plus 5 external practices × $400K. Year 3: $13.5M at 90 physicians × $120K plus 18 external practices × $400K, plus $4–8M of shared-savings upside.
The assumptions. 70% internal adoption, 60% external adoption, an 8% shared-savings rate, stable attribution volume.
And the collection problem it all rests on. The platform is funded 60% from denial-leakage recovery and 40% from ASC operating-income allocation inside the $9M envelope, at a total cost of $2.1–3.5M over 36 months — a $2.1M vendor quote plus 2 FTE × $175K × 3 years plus 10% contingency. Terminate if variance against manual abstraction exceeds 8% by Month 18, or fewer than 40 physicians sign licensing agreements by Month 24.
| Metric | Target | By |
|---|---|---|
| Platform variance vs manual abstraction | ≤5 % by Month 18 | Month 18 |
| Physician licensing adoption rate | 70 % of 128 physicians by Month 24 | Month 24 |
| External practice licensing ARR | $7.2 M by Month 36 | Month 36 |
Three different kinds of money, and none of them is a price increase. $6–9M a year in denials the group is entitled to and does not collect; a $91.2M shared-savings pool it cannot claim against because it cannot measure its own costs; and a capability worth $400K a year to practices facing the same problem.
The negotiating point is the sharpest of the three. Being able to calculate total cost of care at a 30-day lag changes what the group can agree to — specifically, downside caps priced with actuarial precision rather than accepted on the payer's terms. That is pricing power in a business that supposedly has none.
Read a complete Percision report — every page, no email required.
FAQ
Is underpricing really the main issue for providers, or is it collections? For most providers, the realization gap — denials, under-coding, self-pay bad debt — is the larger and safer opportunity than list-price changes, because recovering owed revenue carries no volume risk. Pricing Power Analysis is what tells you which lever actually applies to which segment.
How is pricing power different in fixed-reimbursement lines like Medicare? You have essentially none on price for government payers. There the framework redirects you to mix, cost-to-serve, and realization — not rate negotiation.
Can we do this analysis without software? Yes. A disciplined finance lead with payer-mix and realization data can run this in a spreadsheet. Software earns its place when you're analyzing many segments, need speed, or want structured scenario decks for the board.
Want to pressure-test your pricing power across payers and service lines quickly? You can run the framework yourself at percision.app — then bring the output to your team as a starting point, not a verdict.